Showing results (691-700 of 790) with videos related to

Sort By:
Pageof 79
Pharmaceutics|April 30, 2021
Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation and In Vivo StudiesAnroop B Nair, Jigar Shah, Bandar E Al-Dhubiab, et al.
Applied and Environmental Microbiology|August 31, 2000
Virulence genes in environmental strains of Vibrio choleraeS Chakraborty, A K Mukhopadhyay, R K Bhadra, et al.
Journal of Clinical Microbiology|January 9, 2003
Phenotypic and genotypic characterization of provisional serotype Shigella flexneri 1c and clonal relationships with 1a and 1b strains isolated in BangladeshKaisar A Talukder, Zhahirul Islam, M Aminul Islam, et al.
International Journal of Nanomedicine|October 12, 2012
Anti-HIV-1 nanotherapeutics: promises and challenges for the futureSupriya D Mahajan, Ravikumar Aalinkeel, Wing-Cheung Law, et al.
Journal of Epidemiology and Global Health|September 22, 2020
Epidemic Landscape and Forecasting of SARS-CoV-2 in IndiaAravind Lathika Rajendrakumar, Anand Thakarakkattil Narayanan Nair, Charvi Nangia, et al.
Epidemiology and Infection|November 1, 2000
Clonal dissemination of Vibrio parahaemolyticus displaying similar DNA fingerprint but belonging to two different serovars (O3:K6 and O4:K68) in Thailand and IndiaN R Chowdhury, S Chakraborty, B Eampokalap, et al.
Biochemistry|January 31, 2012
Two ZnF-UBP domains in isopeptidase T (USP5)George V Avvakumov, John R Walker, Sheng Xue, et al.
Nanoscale|February 27, 2020
Voltage-driven annihilation and creation of magnetic vortices in Ni discsM Ghidini, R Mansell, R Pellicelli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 25, 2012
Culture-independent real-time PCR reveals extensive polymicrobial infections in hospitalized diarrhoea cases in Kolkata, IndiaA Sinha, S SenGupta, S Guin, et al.
Vaccine|June 16, 2009
Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune responseD Mahalanabis, T Ramamurthy, G B Nair, et al.
Pageof 79